Phase 2 Natural Killer/T-cell Lymphoma Clinical Trials
7 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–7 of 7 trials
Recruiting
Phase 2
Sintilimab With P-GEMOX Versus the P-GEMOX in the Teatment of Advanced-stage Extranodal Natural Killer/T Cell Lymphoma
Natural Killer/T-Cell Lymphoma, Nasal and Nasal-Type
Sun Yat-sen University84 enrolled1 locationNCT06583083
Recruiting
Phase 2
Screening Study of Combined Sequential Chemotherapy and Radiation Therapy for Early-stage NK/T-cell Lymphoma
Natural Killer/T-Cell Lymphoma, Nasal and Nasal-Type
Fudan University210 enrolled7 locationsNCT06314334
Recruiting
Phase 2
PD-1 Antibody-based Therapy With Concurrent RT for Early-stage NKTCL
Natural Killer/T-cell Lymphoma
Ruijin Hospital47 enrolled1 locationNCT07380984
Recruiting
Phase 1Phase 2
A Phase Ib/II Clinical Study Evaluating the Safety and Efficacy of Tislelizumab in Combination With Golidocitinib and Selinexor for the Treatment of R/R NKTCL
Natural Killer/T-cell LymphomaRelapsed or Refractory Lymphoma Including ENKL
Fudan University68 enrolled1 locationNCT06966154
Recruiting
Phase 2
Phase II Study of Golidocitinib and Benmelstobart in Patients with R/R ENKTL (JACKPOT50)
Natural Killer/T-cell Lymphoma
Sun Yat-sen University47 enrolled2 locationsNCT06733051
Recruiting
Phase 1Phase 2
Linperlisib Combined With Camrelizumab and Pegaspargase in Advanced or Relapsed/Refractory NK/T-cell Lymphoma
T-lymphoblastic LymphomaNatural Killer/T-Cell Lymphoma, Nasal and Nasal-Type
Beijing Tongren Hospital43 enrolled1 locationNCT06376721
Recruiting
Phase 2
Study of Isatuximab and Cemiplimab in Relapsed or Refractory Natural Killer/T-cell Lymphoid Malignancy
Natural Killer/T-cell LymphomaRelapsed Natural Killer/T-cell LymphomaRefractory Natural Killer/T-cell Lymphoma
Won Seog Kim37 enrolled1 locationNCT04763616